Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hofmann, W.-K.
Right arrow Articles by Koeffler, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hofmann, W.-K.
Right arrow Articles by Koeffler, H. P.
Related Collections
Right arrow Neoplasia
Right arrow Apoptosis
Right arrow Gene Expression
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 August 2001, Vol. 98, No. 3, pp. 787-794

NEOPLASIA

Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray

Wolf-K. Hofmann, Sven de Vos, Kunihiro Tsukasaki, William Wachsman, Geraldine S. Pinkus, Jonathan W. Said, and H. Phillip Koeffler

An imbalance between cellular apoptosis and survival may be critical for the pathogenesis of lymphoma. Therefore, the gene expression pattern in lymph node preparations from patients with mantle cell lymphoma (MCL) was compared to the pattern in nonmalignant hyperplastic lymph nodes (HLs). Oligonucleotide microarray analysis was performed comparing 5 MCLs to 4 HLs using high-density microarrays. The expression data were analyzed using Genespring software. For confirmation, the expression of selected genes was analyzed by real-time polymerase chain reaction using the RNA extracted from 16 MCL and 12 HL samples. The focus was on 42 genes that were at least 3-fold down-regulated in MCL; in addition to the B-cell leukemia 2 (BCL2) system other apoptotic pathways were altered in MCL. The FAS-associated via death domain (FADD) gene that acts downstream of the FAS cascade as a key gene to induce apoptosis was more than 10-fold down-regulated in MCL. Furthermore, the death-associated protein 6 (DAXX) gene, the caspase 2 (CASP2) gene, and the RIPK1 domain containing adapter with death domain (RAIDD) gene, which are key genes in other proapoptotic pathways, were also decreased in the MCL samples. The suggestion is made that in addition to the known overexpression of cyclin D1, which drives entry into the cell cycle, disturbances of pathways associated with apoptosis contribute to the development of MCL.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Q. Lan, L. M. Morton, B. Armstrong, P. Hartge, I. Menashe, T. Zheng, M. P. Purdue, J. R. Cerhan, Y. Zhang, A. Grulich, et al.
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies
Blood, July 9, 2009; 114(2): 264 - 267.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. H. Ho, R. Taylor, L. Dorstyn, D. Cakouros, P. Bouillet, and S. Kumar
A tumor suppressor function for caspase-2
PNAS, March 31, 2009; 106(13): 5336 - 5341.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Gelebart, M. Anand, H. Armanious, A. C. Peters, J. Dien Bard, H. M. Amin, and R. Lai
Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma
Blood, December 15, 2008; 112(13): 5171 - 5179.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. A. Tucker, A. I. Kapanen, G. Chikh, B. G. Hoffman, A. H. Kyle, I. M. Wilson, D. Masin, R. D. Gascoyne, M. Bally, and R. J. Klasa
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-{kappa}B, p53, bax, and p27 levels
Mol. Cancer Ther., April 1, 2008; 7(4): 749 - 758.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Kawamata, J. Chen, and H. P. Koeffler
Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells
Blood, October 1, 2007; 110(7): 2667 - 2673.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
S. Elmore
Apoptosis: A Review of Programmed Cell Death
Toxicol Pathol, June 1, 2007; 35(4): 495 - 516.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Perez-Galan, G. Roue, N. Villamor, E. Campo, and D. Colomer
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak
Blood, May 15, 2007; 109(10): 4441 - 4449.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
O. A. O'Connor
Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways
Hematology, January 1, 2007; 2007(1): 270 - 276.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Rudelius, S. Pittaluga, S. Nishizuka, T. H.-T. Pham, F. Fend, E. S. Jaffe, L. Quintanilla-Martinez, and M. Raffeld
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Blood, September 1, 2006; 108(5): 1668 - 1676.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
S. Ek, U. Andreasson, S. Hober, C. Kampf, F. Ponten, M. Uhlen, H. Merz, and C. A. K. Borrebaeck
From Gene Expression Analysis to Tissue Microarrays: A Rational Approach to Identify Therapeutic and Diagnostic Targets in Lymphoid Malignancies
Mol. Cell. Proteomics, June 1, 2006; 5(6): 1072 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Ikezoe, S. Gery, D. Yin, J. O'Kelly, L. Binderup, N. Lemp, H. Taguchi, and H. P. Koeffler
CCAAT/Enhancer-Binding Protein {delta}: A Molecular Target of 1,25-Dihydroxyvitamin D3 in Androgen-Responsive Prostate Cancer LNCaP Cells
Cancer Res., June 1, 2005; 65(11): 4762 - 4768.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Dernbach, C. Urbich, R. P. Brandes, W. K. Hofmann, A. M. Zeiher, and S. Dimmeler
Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress
Blood, December 1, 2004; 104(12): 3591 - 3597.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. J. de Leeuw, J. J. Davies, A. Rosenwald, G. Bebb, R. D. Gascoyne, M. J.S. Dyer, L. M. Staudt, J. A. Martinez-Climent, and W. L. Lam
Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes
Hum. Mol. Genet., September 1, 2004; 13(17): 1827 - 1837.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. M. Dring, F. E. Davies, J. A. L. Fenton, P. L. Roddam, K. Scott, D. Gonzalez, S. Rollinson, A. C. Rawstron, K. S. Rees-Unwin, C. Li, et al.
A Global Expression-based Analysis of the Consequences of the t(4;14) Translocation in Myeloma
Clin. Cancer Res., September 1, 2004; 10(17): 5692 - 5701.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. L. Ebert and T. R. Golub
Genomic approaches to hematologic malignancies
Blood, August 15, 2004; 104(4): 923 - 932.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Zettl, T. Rudiger, M.-A. Konrad, A. Chott, I. Simonitsch-Klupp, R. Sonnen, H. K. Muller-Hermelink, and G. Ott
Genomic Profiling of Peripheral T-Cell Lymphoma, Unspecified, and Anaplastic Large T-Cell Lymphoma Delineates Novel Recurrent Chromosomal Alterations
Am. J. Pathol., May 1, 2004; 164(5): 1837 - 1848.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Thieblemont, V. Nasser, P. Felman, K. Leroy, S. Gazzo, E. Callet-Bauchu, B. Loriod, S. Granjeaud, P. Gaulard, C. Haioun, et al.
Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis
Blood, April 1, 2004; 103(7): 2727 - 2737.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Martinez, F. I. Camacho, P. Algara, A. Rodriguez, A. Dopazo, E. Ruiz-Ballesteros, P. Martin, J. A. Martinez-Climent, J. Garcia-Conde, J. Menarguez, et al.
The Molecular Signature of Mantle Cell Lymphoma Reveals Multiple Signals Favoring Cell Survival
Cancer Res., December 1, 2003; 63(23): 8226 - 8232.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. J. Park, P. T. Vuong, S. de Vos, D. Douer, and H. P. Koeffler
Comparative analysis of genes regulated by PML/RAR{alpha} and PLZF/RAR{alpha} in response to retinoic acid using oligonucleotide arrays
Blood, November 15, 2003; 102(10): 3727 - 3736.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L.-Y. Chen and J. D. Chen
Daxx Silencing Sensitizes Cells to Multiple Apoptotic Pathways
Mol. Cell. Biol., October 15, 2003; 23(20): 7108 - 7121.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. Greil, G. Anether, K. Johrer, and I. Tinhofer
Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools
J. Leukoc. Biol., September 1, 2003; 74(3): 311 - 330.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Heeschen, A. Aicher, R. Lehmann, S. Fichtlscherer, M. Vasa, C. Urbich, C. Mildner-Rihm, H. Martin, A. M. Zeiher, and S. Dimmeler
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization
Blood, August 15, 2003; 102(4): 1340 - 1346.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Vallat, H. Magdelenat, H. Merle-Beral, P. Masdehors, G. Potocki de Montalk, F. Davi, M. Kruhoffer, L. Sabatier, T. F. Orntoft, and J. Delic
The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays
Blood, June 1, 2003; 101(11): 4598 - 4606.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. Assmus, C. Urbich, A. Aicher, W. K. Hofmann, J. Haendeler, L. Rossig, I. Spyridopoulos, A. M. Zeiher, and S. Dimmeler
HMG-CoA Reductase Inhibitors Reduce Senescence and Increase Proliferation of Endothelial Progenitor Cells via Regulation of Cell Cycle Regulatory Genes
Circ. Res., May 16, 2003; 92(9): 1049 - 1055.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris
Cell cycle deregulation in B-cell lymphomas
Blood, February 15, 2003; 101(4): 1220 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
H. Ullah, J.-G. Chen, B. Temple, D. C. Boyes, J. M. Alonso, K. R. Davis, J. R. Ecker, and A. M. Jones
The {beta}-Subunit of the Arabidopsis G Protein Negatively Regulates Auxin-Induced Cell Division and Affects Multiple Developmental Processes
PLANT CELL, February 1, 2003; 15(2): 393 - 409.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W.-K. Hofmann, S. de Vos, M. Komor, D. Hoelzer, W. Wachsman, and H. P. Koeffler
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow
Blood, November 15, 2002; 100(10): 3553 - 3560.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. K. M. Kim, Y. Wang, A. Gambotto, Y.-M. Kim, R. Weller, B. S. Zuckerbraun, Y. Hua, S. C. Watkins, and T. R. Billiar
Hepatocyte Fas-associating Death Domain Protein/Mediator of Receptor-induced Toxicity (FADD/MORT1) Levels Increase in Response to Pro-apoptotic Stimuli
J. Biol. Chem., October 4, 2002; 277(41): 38855 - 38862.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
L Leoncini, S Lazzi, C Bellan, and P Tosi
Cell kinetics and cell cycle regulation in lymphomas
J. Clin. Pathol., September 1, 2002; 55(9): 648 - 655.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
R. S. Robetorye, S. D. Bohling, J. W. Morgan, G. C. Fillmore, M. S. Lim, and K. S. J. Elenitoba-Johnson
Microarray Analysis of B-Cell Lymphoma Cell Lines with the t(14;18)
J. Mol. Diagn., August 1, 2002; 4(3): 123 - 136.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ek, C.-M. Hogerkorp, M. Dictor, M. Ehinger, and C. A. K. Borrebaeck
Mantle Cell Lymphomas Express a Distinct Genetic Signature Affecting Lymphocyte Trafficking and Growth Regulation as Compared with Subpopulations of Normal Human B Cells
Cancer Res., August 1, 2002; 62(15): 4398 - 4405.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Schoch, A. Kohlmann, S. Schnittger, B. Brors, M. Dugas, S. Mergenthaler, W. Kern, W. Hiddemann, R. Eils, and T. Haferlach
Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles
PNAS, July 23, 2002; 99(15): 10008 - 10013.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020